Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers.

Chi P, Allis CD, Wang GG.

Nat Rev Cancer. 2010 Jul;10(7):457-69. doi: 10.1038/nrc2876. Review.

2.

Histone onco-modifications.

Füllgrabe J, Kavanagh E, Joseph B.

Oncogene. 2011 Aug 4;30(31):3391-403. doi: 10.1038/onc.2011.121. Epub 2011 Apr 25. Review.

PMID:
21516126
3.

Interplay between different epigenetic modifications and mechanisms.

Murr R.

Adv Genet. 2010;70:101-41. doi: 10.1016/B978-0-12-380866-0.60005-8. Review.

PMID:
20920747
4.

Dynamic protein methylation in chromatin biology.

Ng SS, Yue WW, Oppermann U, Klose RJ.

Cell Mol Life Sci. 2009 Feb;66(3):407-22. doi: 10.1007/s00018-008-8303-z. Review.

5.

PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks.

Baker LA, Allis CD, Wang GG.

Mutat Res. 2008 Dec 1;647(1-2):3-12. doi: 10.1016/j.mrfmmm.2008.07.004. Epub 2008 Jul 17. Review.

6.

Histone modifications and cancer.

Sawan C, Herceg Z.

Adv Genet. 2010;70:57-85. doi: 10.1016/B978-0-12-380866-0.60003-4. Review.

PMID:
20920745
7.
8.

New advances of DNA methylation and histone modifications in rheumatoid arthritis, with special emphasis on MeCP2.

Miao CG, Yang YY, He X, Li J.

Cell Signal. 2013 Apr;25(4):875-82. doi: 10.1016/j.cellsig.2012.12.017. Epub 2012 Dec 29. Review.

PMID:
23277203
9.

Histone modification therapy of cancer.

Biancotto C, Frigè G, Minucci S.

Adv Genet. 2010;70:341-86. doi: 10.1016/B978-0-12-380866-0.60013-7. Review.

PMID:
20920755
10.

Histone acetylation and chromatin signature in stem cell identity and cancer.

Shukla V, Vaissière T, Herceg Z.

Mutat Res. 2008 Jan 1;637(1-2):1-15. Epub 2007 Aug 1. Review.

PMID:
17850830
11.

Chromatin remodeling and cancer, Part I: Covalent histone modifications.

Wang GG, Allis CD, Chi P.

Trends Mol Med. 2007 Sep;13(9):363-72. Epub 2007 Sep 5. Review.

PMID:
17822958
12.

Histone lysine methylation and demethylation pathways in cancer.

Varier RA, Timmers HT.

Biochim Biophys Acta. 2011 Jan;1815(1):75-89. doi: 10.1016/j.bbcan.2010.10.002. Epub 2010 Oct 15. Review.

PMID:
20951770
13.

Histone demethylases and cancer.

Kampranis SC, Tsichlis PN.

Adv Cancer Res. 2009;102:103-69. doi: 10.1016/S0065-230X(09)02004-1. Review.

14.

The enigmatic role of H2Bub1 in cancer.

Johnsen SA.

FEBS Lett. 2012 Jun 4;586(11):1592-601. doi: 10.1016/j.febslet.2012.04.002. Epub 2012 Apr 13. Review.

15.

Epigenetic gene regulation in cancer.

Ballestar E, Esteller M.

Adv Genet. 2008;61:247-67. doi: 10.1016/S0065-2660(07)00009-0. Review.

PMID:
18282509
16.

Cross-talk among epigenetic modifications: lessons from histone arginine methylation.

Molina-Serrano D, Schiza V, Kirmizis A.

Biochem Soc Trans. 2013 Jun;41(3):751-9. doi: 10.1042/BST20130003. Review.

PMID:
23697934
17.

Histone modifications as a pathogenic mechanism of colorectal tumorigenesis.

Gargalionis AN, Piperi C, Adamopoulos C, Papavassiliou AG.

Int J Biochem Cell Biol. 2012 Aug;44(8):1276-89. doi: 10.1016/j.biocel.2012.05.002. Epub 2012 May 11. Review.

PMID:
22583735
18.

Epigenetic interplay of histone modifications and DNA methylation mediated by HDA6.

Liu X, Luo M, Wu K.

Plant Signal Behav. 2012 Jun;7(6):633-5. doi: 10.4161/psb.19994. Epub 2012 May 14. Review.

19.

Roles of histone methyl-modifying enzymes in development and progression of cancer.

Suzuki T, Terashima M, Tange S, Ishimura A.

Cancer Sci. 2013 Jul;104(7):795-800. doi: 10.1111/cas.12169. Epub 2013 May 9. Review.

20.

Epigenetic cross-talk between DNA methylation and histone modifications in human cancers.

Kondo Y.

Yonsei Med J. 2009 Aug 31;50(4):455-63. doi: 10.3349/ymj.2009.50.4.455. Epub 2009 Aug 19. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk